Preclinical work using a xenogeneic model, where human RA synovial tissue was transplanted into severe combined immunodeficient mice, demonstrated that mice treated with BiP/1805 showed reduced tissue expression of HLA‐DR, CD86 and production of IL‐6 and TNF‐α.118. Here, HSPA5 is linked to rheumatoid arthritis.